GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 111 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $757,000 | -79.9% | 51,858 | -80.4% | 0.10% | -79.8% |
| Q3 2020 | $3,758,000 | -7.2% | 264,141 | -3.8% | 0.48% | -9.9% |
| Q2 2020 | $4,048,000 | -13.9% | 274,686 | -71.9% | 0.53% | +6.7% |
| Q4 2019 | $4,702,000 | +21.1% | 977,526 | +52.6% | 0.49% | +22.0% |
| Q3 2019 | $3,882,000 | -6.2% | 640,547 | +0.4% | 0.40% | -0.7% |
| Q2 2019 | $4,140,000 | -13.1% | 637,949 | -5.0% | 0.41% | -11.5% |
| Q1 2019 | $4,762,000 | +22.4% | 671,603 | -16.1% | 0.46% | +19.4% |
| Q4 2018 | $3,892,000 | +16.4% | 800,756 | +76.0% | 0.39% | +52.0% |
| Q3 2018 | $3,345,000 | +15.2% | 455,064 | -0.0% | 0.25% | +17.6% |
| Q2 2018 | $2,903,000 | +26.6% | 455,077 | +8.0% | 0.22% | +20.0% |
| Q1 2018 | $2,293,000 | +1.1% | 421,433 | -22.5% | 0.18% | +13.9% |
| Q4 2017 | $2,267,000 | -32.3% | 543,715 | +56.4% | 0.16% | -35.5% |
| Q3 2017 | $3,347,000 | – | 347,565 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
| Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
| Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
| Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
| Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
| Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
| WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |